EXEMPTIA (Adalimumab) Injection

EXEMPTIA, is an prescription medication. Its used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and uveitis. It is administered by subcutaneous injection (injection under the skin).

Facts of EXEMPTIA (adalimumab)
Trade Name: EXEMPTIA
Generic Name: adalimumab
Date of Approval: 2002
Dosage Forms & Strength: 40mg
Manufacturer: Zydus

Request EXEMPTIA (Adalimumab) Communication – Important Information
If EXEMPTIA (Adalimumab) is not available in your country, and you require assistance to get access this medication under “Named Patient Program (NPP)” treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon, please send us a formal request for communication regarding this medication at urgent@cancermedicinesnetwork.com or call a customer support or WhatsApp your query

Please Note:
EXEMPTIA (Adalimumab) is a prescription medication. A valid prescription from a licensed healthcare provider is required for any request.

 

Get In Touch

Get in touch with us at Verve Biscience, and one of our team will be on hand to help with any queries you may have.

The Verve Biscience is open
Monday to Saturday.
Business hours: 10.00 A.M to 06.00 P.M.

Contact Number:
M:+91-9910645395

Email ID:
info@cancermedicinesnetwork.com
rakeshkhanna.rk@gmail.com

Description

Adalimumab, marketed under the brand name EXEMPTIA, It is an prescription medication that has been approved for medical use in the United States in 2002. It is on the World Health Organization’s List of Essential Medicines.

What is EXEMPTIA (adalimumab) ?

Adalimumab is prescribed to people who have Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis, and to children having Juvenile Idiopathic Arthritis (JIA). Exemptia (adalimumab) is a prescription medicine that can be self-injected. It is used to treat moderate to severe rheumatoid arthritis (RA). Exemptia (adalimumab) is grouped within a class of medications called biologic response modifiers, or biologics.

The recommended initial dose is 160 mg (Day 1) (four 40 mg injections in one day or two 40 mg injections per day for two consecutive days), followed by 80 mg two weeks later (Day 15).

How To Get Access EXEMPTIA (Adalimumab) For Personal Use ?

To get access to EXEMPTIA (Adalimumab), you need a prescription from a doctor, as it is a prescription-only medication. Your prescription will be filled through a specialty pharmacy, which will handle insurance and coordinate delivery of the medication to you. Your doctor will also need to provide specific information for the prescription to be filled correctly.

However, patients in India can legally access it through the provision called the Named Patient Program (NPP). EXEMPTIA (Adalimumab) prices may fluctuate over time because of market dynamics and regulatory changes. It can be imported for personal use under “Named Patient Program” treatment in multiple countries, including the Singapore, Kuala Lumpur (Malaysia), Bangkok (Thailand), Jakarta, Surabaya, Bandung (Indonesia), Manila, Cebu (Philippines), Ho Chi Minh City, Hanoi (Vietnam), Yangon (Myanmar), Phnom Penh (Cambodia), Vientiane (Laos), UAE, Saudi Arabia, Argentina, Brazil, UK, Hungary, Ireland, Latvia, Slovakia, Czech Republic, Belgium, Lithuania, Greece, Spain, Zimbabwe, Australia, and New Zealand.

To order or inquire about EXEMPTIA (Adalimumab) international access, you can contact Verve Biosciences – a trusted pharmaceutical exporter, supplier, and distributor of anti-cancer and specialty medications.

📧 Email: urgent@cancermedicinesnetwork.com
📞 Call or WhatsApp: 9910645395 or 9910645395

Note: Availability may vary by country and is subject to regulatory approvals.

About Healthcare Consultant

Rakesh brings an experience of 37 years in the pharmaceutical industry at various roles and responsibilities in Indian and US pharma MNCs. His areas of operations have been India and Southeast Asia, and he has been running a successful pharma business since 2010.

Testimonials

Frequently Asked Questions (FAQs)

No. At present. This medicine is not approved by the Drug Controller General Of India (DCGI).

It is a prescription medicine. You should have a VALID and RECENT Prescription.

No, we do not sell rather we just FACILITATE the Procurement of this Medicine in India

Yes, We do. Since we facilitate the Procurement of Medicines directly from the International companies and that too with all Legal Documents like International Comp. Invoice, Air Way Bill (AWB) and Bill Of Entry (BOE), we Guarantee for it.

It would take you 12-17 Working Days as it requires Govt Approvals/Certificates and coordination with an International company.

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

A detailed answer to provide information about your business, build trust with potential customers, or help the visitor with a problem they may be encountering

We are 24 Hours * 7 Days Available through our Website and Mobile Numbers?

Related Products